The gluten content in oat products available on the Czech market

https://doi.org/10.17221/114/2018-CJFSCitation:Rysová J., Mašková E., Šmídová Z. (2019): The gluten content in oat products available on the Czech market. Czech J. Food Sci., 37: 345-350.
download PDF

The gluten content in oat products on the market in the Czech Republic was monitored. The ELISA kit Ridascreen gliadin from R-Biopharm based on the R5 antibody was used for the gliadin determination. Oat products (41 samples), including 21 samples of oat flakes, were tested. Only 6 samples were labelled as gluten-free and it was confirmed that these samples meet the criteria for gluten-free foods. The total of 29 oat products, of which 15 were samples of oat flakes, contained more than 20 mg/kg of gluten. This means that 71% of oat cereal products were contaminated with cereals toxic for people with celiac disease. It was shown that most oat products on the Czech market are not safe for people with gluten intolerance.

References:
Aaltonen K., Laurikka P., Huhtala H., Maki M., Kaukinen K., Kurppa K. (2017): The long-term consumption of oats in celiac disease patients is safe: A large cross-sectional study. Nutrients, 9: 611. doi: 10.3390/nu9060611. https://doi.org/10.3390/nu9060611
 
Comino I., de Lourdes Moreno M., Sousa C. (2015): Role of oats in celiac disease. World Journal of Gastroenterology, 21: 11825–11831. https://doi.org/10.3748/wjg.v21.i41.11825
 
Comino I., Bernardo D., Bancel E., de Lourdes-Moreno M., Sanchez B., Barro F., Suligoj T., Ciclitira P.J., Cebolla A., Knight S.C., Branlard G., Sousa C. (2016): Identification and molecular characterization of oat peptides implicated on coeliac immune response. Food & Nutrition Research, 60: 30324. doi: 10.3402/fnr.v60.30324
 
Cooper S.E.J., Kennedy N.P., Mohamed B.M., Abuzakouk M., Dunne J., Byrne G., McDonald G., Davies A., Edwards C., Kelly J., Feighery C.F. (2013): Immunological indicators of coeliac disease activity are not altered by long-term oats challenge. Clinical & Experimental Immunology, 171: 313–318.
 
Daou S., Zhang H. (2012): Oat Beta-Glucan: Its role in health promotion and prevention of diseases. https://doi.org/10.1111/j.1541-4337.2012.00189.x
 
Comprehensive Reviews in Food Science and Food Safety, 11: 355–365.
 
De Souza M.C.P., Deschenes M.E., Laurencelle S., Roy C.C., Djilali-Saiah I. (2016): Pure oats as part of the Canadian gluten-free diet in celiac disease: The need to revisit the issue. Canadian Journal of Gastroenterology and Hepatology, Article ID 1576360, 8 pages. doi.org/10.1155/2016/1576360. https://doi.org/10.1155/2016/1576360
 
Farage P., Boas G.V., Gandolfi L., Oratesi R., Puppin Zandonadi R. (2014): Is the consumption of oats safe for celiac disease patients? A review of literature. Journal of Food and Nutritional Disorders, 3. doi.org/10.4172/2324-9323.1000138.
 
Hernando A., Mujico J.R., Mena M.C., Lombardía M., Méndez E. (2008): Measurement of wheat gluten and barley hordeins in contaminated oats from Europe, the United States and Canada by Sandwich R5 ELISA. European Journal of Gastroenterology and Hepatology, 20: 545–554. https://doi.org/10.1097/MEG.0b013e3282f46597
 
Chmelová D., Ondrejovič M., Havrlentová M., Hozlár P. (2015): Antioxidant activity in naked and hulled oat (Avena sativa l.) varieties. Journal of Microbiology, Biotechnology and Food Sciences, 4: 63–65. https://doi.org/10.15414/jmbfs.2015.4.special3.63-65
 
Kahlenberg F., Sanchez D., Lachman I., Tuckova L., Tlaskalova H., Mendez E., Mothes T. (2006): Monoclonal antibody R5 for detection of putatively coeliac-toxic gliadin peptide. https://doi.org/10.1007/s00217-006-0268-2
 
European Food Research and Technology, 222: 78–82. 
 
Kaukinen K., Collin P., Huhtal, H., Mäki M. (2013): Long-term consumption of oats in adult celiac disease patients. Nutrients, 5: 4380–4389. https://doi.org/10.3390/nu5114380
 
Koenig R., Dickman J. R., Kang Ch., Chu Y. F., Li L. (2014): Avenanthramide supplementation attenuates exercise-induced inflammation in postmenopausal women. Nutrition Journal, 13: 21. doi: 10.1186/1475-2891-13-21. https://doi.org/10.1186/1475-2891-13-21
 
Lerner A. (2014): The enigma of oats in nutritional therapy for celiac disease. International Journal of Celiac Disease, 2: 110–114. https://doi.org/10.12691/ijcd-2-3-1
 
La Vieille S., Pulido O. M., Abbot M., Koerner T., Godefroy S. (2016): Celiac disease and gluten-free oats: A Canadian position based on a literature review., Article ID 1870305, 10 pages. doi: 10.1155/2016/1870305. https://doi.org/10.1155/2016/1870305
 
Pawlovska P., Diowksz A., Kordialik-Bogacka E. (2012): State-of-the-art incorporation of oat into a gluten-free diet. Food Reviews International, 8: 330–342. https://doi.org/10.1080/87559129.2012.660715
 
Pinto-Sanchez M. I., Causada-Calo N., Bercik P., Ford, A.C., Murray J.A., Armstrong D., Semrad C., Kupfer, S.S., Alaedini, A., Moayyedi, P., Leffler, D.A., Verdú, E.F., Green, P. (2017): Safety of adding oats to a gluten-free diet for patients with celiac disease: Systematic review and meta-analysis of clinical and observational studies. Gastroenterology, 153: 395–409. https://doi.org/10.1053/j.gastro.2017.04.009
 
Pulido O. M., Gillespie Z., Zarkadas M., Dubois S., Vavasour E., Rashid M., Switze, C., Godefroy S. B. (2009): Introduction of oats in the diet of individuals with celiac disease: a systematic review. Advances in Food and Nutrition Research, 7: 235–285.
 
Real A., Comino I., de Lorenzo l., Merchan F., Gil-Humanes J., Gimenez M., Lopez-Casado M. A., Torres M. I., Cebolla A., Sousa C., Barr, F., Pisto, F. (2012): Molecular and immunological characterization of gluten proteins isolated from oat cultivars that differ in toxicity for celiac disease. Plos ONE, 7: e48365. doi: 10.1371/journal.pone.0048365. https://doi.org/10.1371/journal.pone.0048365
 
Silano M., Pozo E. P., Uberti F., Manferdelli S., Del Pinto T., Felli C., Budelli A., Vincentini O., Restani P. (2014): Diversity of oat varieties in eliciting the early inflammatory events in celiac disease. European Journal of Nutrition, 53: 1177–1186. https://doi.org/10.1007/s00394-013-0617-4
 
Singh R., De S., Belkheir A. (2013): Avena sativa (Oat), a potencial nutraceutical and therapeutic agent. An overview. Critical Reviews in Food Science and Nutrition, 53: 126–144. https://doi.org/10.1080/10408398.2010.526725
 
Sjöberg V., Hollen E., Pietz G., Magnusson K. E., Magnusson K. F., Sundström M., Holmgren Peterson K., Sundström O., Hernell O., Hammarström S., Högberg L., Hammarström M. L. (2014): Noncontaminated dietary oats may hamper normalization of the intestinal immune status in childhood celiac disease. Clinical and Translational Gastroenterology, 5: e58. doi: 10.1038/ctg.2014.9. https://doi.org/10.1038/ctg.2014.9
 
Tapsas D., Fälth-Magnusson K., Högberh L., Hammersjö J. A., Hollén E. (2014): Swedish children with celiac disease comply well with a gluten-free diet, and most include oats without reporting any adverse effects: a long-term follow-up study. Nutrition research, 34: 436–441. https://doi.org/10.1016/j.nutres.2014.04.006
 
Thompson T. (2004): Gluten contamination of commercial oat products in the United States. New England Journal of Medicine, 351: 2021–2022. https://doi.org/10.1056/NEJM200411043511924
 
download PDF

© 2019 Czech Academy of Agricultural Sciences